Does RAMIPRIL Cause Type v hyperlipidaemia? 22 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Type v hyperlipidaemia have been filed in association with RAMIPRIL (Ramipril). This represents 0.1% of all adverse event reports for RAMIPRIL.
22
Reports of Type v hyperlipidaemia with RAMIPRIL
0.1%
of all RAMIPRIL reports
0
Deaths
3
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From RAMIPRIL?
Of the 22 reports, 3 (13.6%) required hospitalization.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
METFORMIN (19)
Which RAMIPRIL Alternatives Have Lower Type v hyperlipidaemia Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE